Related Experiment Video
Updated: May 6, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms
L D'Olhaberriague1, N Joshi, S Chaturvedi
1Department of Neurology, Wayne State University/Detroit Medical Center, Stroke Program, Detroit, MI; and the Departments of Neurology, Emergency Medicine, and Diagnostic Radiology (Division of Neuroradiology), Center for Stroke Research, Henry Ford Hospital and Health Sciences Center, Detroit, MI.
Abstract:
Intracranial hemorrhage (ICH) is the most feared complication of thrombolytic therapy for acute ischemic stroke. There are limited data on the risks of thrombolysis in patients with asymptomatic intracranial aneurysm. We report 2 adults with signs of hemispheric ischemia who were successfully treated with intravenous tissue plasminogen activator (t-PA), despite the presence of asymptomatic intracranial aneurysm. The presence of an asymptomatic intracranial aneurysm may not necessarily preclude a good outcome from acute ischemic stroke treated with rt-PA. Selected patients harboring incidental, unruptured intracranial aneurysm may benefit from thrombolytics.
Related Concept Videos
Transient Ischemic Attack l: Introduction
Venous Thrombosis III: Interprofessional Care
Aneurysm III: Interprofessional Care
Clot Retraction and Fibrinolysis
Ischemic Stroke l: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

